Viridian Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.0% | -38.9% | +55.4% | +127.2% | -26.9% | +301.3% | -54.4% | -56.7% | -49.6% | -21.8% | +575.8% | -72.4% | +26.6% | -5.9% | -79.7% | -100.0% | – | +2,587.0% | -24.9% | -80.9% | +2.9% | +0.9% | +18.5% | +366.8% | -91.2% | -6.7% | -26.5% | +0.0% | +0.0% | +0.0% | +0.0% | +19.4% | -16.3% | +0.0% | +4.2% | +93,993.3% | -99.8% | +6.8% | +101.4% | – | |
| – | +15.5% | +495.4% | +33.2% | -8.5% | -0.4% | +28.3% | +30.6% | -11.7% | +11.3% | +6.3% | -1.7% | +5.0% | -28.9% | -4.9% | -37.1% | -18.9% | +390.3% | -9.5% | -9.0% | -35.4% | +175.8% | -20.8% | +22.3% | +1.9% | +77.8% | -99.5% | +110.7% | -22.5% | +4.5% | -1.4% | +1,578.6% | – | – | – | – | – | – | -62.2% | -3.3% | – | |
| – | -77.9% | -5,815.6% | – | – | – | – | – | – | – | – | – | – | – | – | -79.7% | -1,951.8% | – | – | – | – | – | – | – | – | – | – | -26.5% | +0.0% | +0.0% | +0.0% | +0.0% | +19.4% | -16.3% | +0.0% | +4.2% | +93,993.3% | -100.3% | – | +101.4% | – | |
| – | -90.7% | +19,519.0% | +33.2% | -8.5% | -0.4% | +28.3% | +30.6% | -11.7% | +11.3% | +6.3% | -1.7% | +5.0% | -6.8% | -27.5% | -37.1% | -18.9% | +390.3% | -9.5% | -9.0% | -35.4% | +175.8% | -20.8% | +22.3% | +1.9% | +77.8% | +29.1% | -21.0% | -24.2% | +26.9% | +6.2% | +37.2% | +23.1% | +4.1% | +6.8% | +12.7% | -0.4% | +3.4% | -13.0% | -7.8% | – | |
| – | +62.6% | +33.9% | -21.3% | -3.1% | +1.8% | +17.3% | -10.8% | +1.0% | 0.0% | +24.6% | -14.9% | +1.4% | -12.6% | +7.5% | -0.6% | -15.0% | +140.8% | +11.3% | +5.9% | -4.6% | +10.9% | +21.1% | -3.0% | +9.3% | +11.2% | +121.5% | -11.8% | +8.5% | +57.8% | -54.5% | +6.9% | -10.3% | +8.2% | +9.7% | +18.2% | +20.3% | +38.5% | +14.9% | +42.1% | – | |
| – | +28.3% | +173.8% | +9.0% | -6.8% | +0.3% | +24.6% | +17.4% | -8.6% | +8.3% | +10.8% | -5.4% | +4.1% | -62.0% | +94.7% | -25.9% | -17.3% | +1,293.7% | -91.8% | +5.9% | -4.6% | +10.9% | +21.1% | -3.0% | +9.3% | +11.2% | +636.5% | -18.2% | -13.6% | +39.5% | -21.8% | +29.1% | +15.6% | +4.8% | +7.3% | +13.7% | +3.5% | +10.8% | -5.1% | +8.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.0% | +173.1% | -9.9% | -9.4% | +227.6% | +10.0% | +2.4% | +3.7% | +2.7% | +1.8% | -1.3% | -10.9% | -16.7% | -17.1% | -33.3% | -1.1% | +93.5% | +0.0% | -100.0% | – | – | +6,433.3% | -21.4% | +6.5% | +2.4% | -1.8% | +0.6% | +261.4% | +52.7% | -35.9% | +1.7% | +68.2% | -14.5% | -31.7% | -12.3% | +8.9% | +1,080.0% | -47.6% | +139.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +240.0% | +10.8% | -31.9% | +116.9% | +116.2% | +0.3% | -20.2% | +17.3% | -39.8% | -34.8% | -62.4% | -46.0% | +22.2% | -245.5% | – | -57.7% | -83.6% | +911.1% | -96.7% | -6,633.3% | – | -487.7% | – | – | – | -103.1% | – | -102.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.